| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 37.77× | 37.77× | 41.93× | 40.67× | 26.74× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| −0.07× | −0.06× | −0.14× | −0.16× | −0.11× | ||
| 0.88× | 0.88× | 1.00× | 0.95× | 0.86× | ||
| −3.10× | −3.10× | −0.40× | −0.48× | −0.49× | ||
| 1.07× | 1.07× | 0.87× | 1.10× | 1.11× |
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 26.74 | 40.67 | 41.93 | 37.77 | 37.77 | |
| Working Capital Turnover | -0.11 | -0.16 | -0.14 | -0.06 | -0.07 | |
| Asset Turnover | 0.86 | 0.95 | 1.00 | 0.88 | 0.88 | |
| Cash Conversion (CFO/Net Income) | -0.49 | -0.48 | -0.40 | -3.10 | -3.10 | |
| CFO/EBITDA | 1.11 | 1.10 | 0.87 | 1.07 | 1.07 |